Therapeutic Clinical Intelligence-Psoriasis

Table of Contents

Section 1: Executive Summary

• Psoriasis Disease Overview
• Classification of Psoriasis
• Disease Epidemiology: U.S. & European Prevalence
• Disease Epidemiology-Patient Segmentation
• Psoriasis Treatment Paradigm
• Conventional Psoriasis Therapies
• Overview of Competitive Landscape
• Ongoing Psoriasis Clinical Trials

Section 2: The Current Market Leaders in Psoriasis

• Enbrel (etanercept)
• Remicade (infliximab)
• Humira (adalimumab)
• Raptiva

Section 3: Future Competitive Threats

• CNTO-1275
• Golimumab (CNTO-148)
• ABT-874
• Cimzia
• Zanolimumab

Section 4: Early Stage Development Programs: Products on the Radar

• BMS-582949
• Apremilast
• BIRT 2584XX
• AMG-714
• BCX-4208
• MEDI-545

Section 5: Appendix

• Disclaimer
• Report Licensing